Current News

Contact | Print version | Send article | RSS feed

Xceleron and Covance enter co-promotional agreement

17 Nov 2006 - Xceleron announced a cooperation agreement with Covance in which both companies will make available each others drug development services to their customers. In addition Xceleron and Covance will carry out joint projects on behalf of sponsors and to further the development of new applications.
 
Xceleron CEO, Professor Colin Garner commented that "this is a strategically important deal for Xceleron. It demonstrates how quickly our technology has moved from being seen as novel and at the edges of drug development to its acceptance as a mainstream part of the drug development process. Covance is a great partner to have and this agreement will add global marketing power to our business; we look forward to working closely with them".